MAP2K7 and cancer: Accumulating evidences indicate that PGE2 exerts oncogenic function in cancer via its receptor EP receptors [12, 13] and its downstream signaling, including Ras-Raf-MEK-ERK and GSK3-beta/β-Catenin [32].